Segmentation - Vision Impairment Market

Vision Impairment Market, By Type (Refractive Errors, Macular Degeneration, Retinitis Pigmentosa, Night Blindness, Others), By Treatment (Surgery, Devices, Medications, Others), By Route of Administration (Oral, Topical, Implant, Intravitreal, Others), By End User (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

掲載誌 : Jun 2026
Code : CMI5598
ページ :250+
フォーマット :
Excel and PDF
産業 : Medical Devices
역사적 분포 범위 : 2020 - 2024
기준 연도 : 2025
예상 연도 : 2026
예측 기간 : 2026 - 2033

N/A

Market Segmentation

By Type (Revenue, USD Bn, 2021-2033)
- Refractive Errors
- Macular Degeneration
- Retinitis Pigmentosa
- Night Blindness
- Others
By Treatment (Revenue, USD Bn, 2021-2033)
- Surgery
- Devices
- Medications
- Others
By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Topical
- Implant
- Intravitreal
- Others
By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Specialty Clinics
- Homecare
- Others
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
By Region: (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Competitive Landscape
- Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Bayer AG
- Eli Lilly and Company
- Merck & Co., Inc.
- Regeneron Pharmaceuticals Inc.
- Allergan
- Neurotech, LLC
- Gilead Sciences, Inc.
- Adverum
- STEMCELL Technologies Inc.
- IVERIC bio
- Kubota Pharmaceutical Holdings Co. Ltd.
- Sanwa Kagaku Kenkyusho Co., Ltd
- Opthea Limited
- Santen Pharmaceutical Co., Ltd
- PanOptica, Inc
- Alcon
- Phio Pharmaceuticals Corp
- Bausch Health Companies Inc.